Lockheed Martin Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Lockheed Martin Investment Management's BIIB Position: Q2 2018 in Review
Lockheed Martin Investment Management sold out of Biogen (BIIB) in Q2 2018, closing a stake of 3,000 shares — an estimated $821K sold.
Lockheed Martin Investment Management first reported a position in BIIB in Q4 2013 and held it in 9 quarters. The position peaked at $8.25M in Q4 2013. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.
- Lockheed Martin Investment Management reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
- Lockheed Martin Investment Management sold 3,000 Biogen shares in Q2 2018, an estimated $821K.
- Lockheed Martin Investment Management first reported a position in Biogen in Q4 2013 and held it in 9 quarters.
- Lockheed Martin Investment Management's Biogen position peaked at $8.25M in Q4 2013.
- 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.
Based on Lockheed Martin Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.